Literature DB >> 34970429

Recent advances in liver transplantation.

N Thomas Burke1, James B Maurice1, David Nasralla2, Jonathan Potts1, Rachel Westbrook1.   

Abstract

Liver transplant is a life-saving treatment with 1-year and 5-year survival rates of 90% and 70%, respectively. However, organ demand continues to exceed supply, such that many patients will die waiting for an available organ. This article reviews for the general gastroenterologist the latest developments in the field to reduce waiting list mortality and maximise utilisation of available organs. The main areas covered include legislative changes in organ donation and the new 'opt-out' systems being rolled out in the UK, normothermic machine perfusion to optimise marginal grafts, a new national allocation system to maximise benefit from each organ and developments in patient 'prehabilitation' before listing. Current areas of research interest, such as immunosuppression withdrawal, are also summarised. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  liver transplantation

Year:  2021        PMID: 34970429      PMCID: PMC8666869          DOI: 10.1136/flgastro-2020-101425

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  36 in total

1.  Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.

Authors:  Carlos Benítez; María-Carlota Londoño; Rosa Miquel; Tommaso-Maria Manzia; Juan G Abraldes; Juan-José Lozano; Marc Martínez-Llordella; Marta López; Roberta Angelico; Felix Bohne; Pilar Sese; Frederic Daoud; Patrick Larcier; Dave L Roelen; Frans Claas; Gavin Whitehouse; Jan Lerut; Jacques Pirenne; Antoni Rimola; Giuseppe Tisone; Alberto Sánchez-Fueyo
Journal:  Hepatology       Date:  2013-09-19       Impact factor: 17.425

2.  Analysis of causes of death in liver transplant recipients who survived more than 3 years.

Authors:  J Pruthi; K A Medkiff; K T Esrason; J A Donovan; E M Yoshida; S R Erb; U P Steinbrecher; T L Fong
Journal:  Liver Transpl       Date:  2001-09       Impact factor: 5.799

Review 3.  An appraisal of tolerance in liver transplantation.

Authors:  J Lerut; A Sanchez-Fueyo
Journal:  Am J Transplant       Date:  2006-08       Impact factor: 8.086

Review 4.  Biomarkers of immune tolerance in liver transplantation.

Authors:  Julien Vionnet; Alberto Sánchez-Fueyo
Journal:  Hum Immunol       Date:  2018-02-17       Impact factor: 2.850

5.  Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity.

Authors:  Elena Dionigi; Matteo Garcovich; Mauro Borzio; Gioacchino Leandro; Avik Majumdar; Aikaterini Tsami; Vasiliki Arvaniti; Davide Roccarina; Massimo Pinzani; Andrew K Burroughs; James O'Beirne; Emmanuel A Tsochatzis
Journal:  Am J Gastroenterol       Date:  2017-02-21       Impact factor: 10.864

6.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

7.  Selection of patients for liver transplantation and allocation of donated livers in the UK.

Authors:  J Neuberger; A Gimson; M Davies; M Akyol; J O'Grady; A Burroughs; M Hudson
Journal:  Gut       Date:  2007-09-25       Impact factor: 23.059

8.  Prognostic benefit of the addition of a quantitative index of hepatic encephalopathy to the MELD score: the MELD-EEG.

Authors:  Sara Montagnese; Michele De Rui; Sami Schiff; Elena Ceranto; Pietro Valenti; Paolo Angeli; Umberto Cillo; Giacomo Zanus; Angelo Gatta; Piero Amodio; Carlo Merkel
Journal:  Liver Int       Date:  2014-03-12       Impact factor: 5.828

9.  Prednisolone or pentoxifylline for alcoholic hepatitis.

Authors:  Mark R Thursz; Paul Richardson; Michael Allison; Andrew Austin; Megan Bowers; Christopher P Day; Nichola Downs; Dermot Gleeson; Alastair MacGilchrist; Allister Grant; Steven Hood; Steven Masson; Anne McCune; Jane Mellor; John O'Grady; David Patch; Ian Ratcliffe; Paul Roderick; Louise Stanton; Nikhil Vergis; Mark Wright; Stephen Ryder; Ewan H Forrest
Journal:  N Engl J Med       Date:  2015-04-23       Impact factor: 91.245

10.  Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation.

Authors:  Alberto Sánchez-Fueyo; Gavin Whitehouse; Nathali Grageda; Matthew E Cramp; Tiong Y Lim; Marco Romano; Sarah Thirkell; Katie Lowe; Laura Fry; Julie Heward; Alex Kerr; Jakia Ali; Chris Fisher; Gillian Lewis; Andrew Hope; Elisavet Kodela; Mike Lyne; Farzin Farzaneh; Shahram Kordasti; Irene Rebollo-Mesa; Juan Jose Lozano; Niloufar Safinia; Nigel Heaton; Robert Lechler; Marc Martínez-Llordella; Giovanna Lombardi
Journal:  Am J Transplant       Date:  2020-02-03       Impact factor: 8.086

View more
  1 in total

1.  Twitter debate: controversies in liver transplantation.

Authors:  Oliver D Tavabie; Ankur Srivastava; Audrey Dillon; Darius Mirza; Steven Masson; Philip J Smith
Journal:  Frontline Gastroenterol       Date:  2021-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.